JY
GYRE icon

Jeff Yass’s Gyre Therapeutics GYRE Stock Holding History

Jeff Yass’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,427
Closed -$44K – 13419
2021
Q3 		$44K Buy
+1,427
New +$47K ﹤0.01% 12384
2021
Q2 		– Sell
-3,227
Closed -$122K – 12825
2021
Q1 		$122K Buy
+3,227
New +$147K ﹤0.01% 11766
2020
Q3 		– Sell
-7,000
Closed -$308K – 10767
2020
Q2 		$308K Sell
7,000
-1,347
-16% -$63.2K ﹤0.01% 8316
2020
Q1 		$274K Buy
8,347
+6,854
+459% +$315K ﹤0.01% 8154
2019
Q4 		$76K Buy
+1,493
New +$62.6K ﹤0.01% 9230
2019
Q2 		– Sell
-6,987
Closed -$425K – 10458
2019
Q1 		$425K Buy
6,987
+654
+10% +$42K ﹤0.01% 6581
2018
Q4 		$375K Sell
6,333
-16,840
-73% -$1.24M ﹤0.01% 6582
2018
Q3 		$1.87M Sell
23,173
-3,040
-12% -$241K ﹤0.01% 4114
2018
Q2 		$2.29M Buy
26,213
+2,453
+10% +$430K ﹤0.01% 3780
2018
Q1 		$4.6M Buy
+23,760
New +$4.43M ﹤0.01% 2646
2017
Q2 		– Sell
-1,707
Closed -$121K – 9420
2017
Q1 		$121K Buy
+1,707
New +$99.7K ﹤0.01% 8309
2014
Q3 		– Sell
-165
Closed -$587K – 9620
2014
Q2 		$587K Buy
165
+138
+511% +$450K ﹤0.01% 7168
2014
Q1 		$100K Sell
27
-187
-87% -$692K ﹤0.01% 8564
2013
Q4 		$698K Buy
214
+73
+52% +$288K ﹤0.01% 6147
2013
Q3 		$588K Sell
141
-172
-55% -$692K ﹤0.01% 6175
2013
Q2 		$1.05M Buy
+313
New +$1.19M ﹤0.01% 4902

Other funds holding GYRE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jeff Yass's GYRE Position: Q3 2025 in Review

Jeff Yass sold out of Gyre Therapeutics (GYRE) in Q3 2025, closing a stake of 35,912 shares — an estimated $264K sold.

Jeff Yass first reported a position in GYRE in Q2 2013 and held it in 25 quarters. The position peaked at $2.36M in Q1 2018. 48 funds tracked by Wall St. Rank hold GYRE as of Q3 2025.

  • Jeff Yass reported no remaining Gyre Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jeff Yass sold 35,912 Gyre Therapeutics shares in Q3 2025, an estimated $264K.
  • Jeff Yass first reported a position in Gyre Therapeutics in Q2 2013 and held it in 25 quarters.
  • Jeff Yass's Gyre Therapeutics position peaked at $2.36M in Q1 2018.
  • 48 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.